Unraveling the functional implications of GWAS: how T cell protein tyrosine phosphatase drives autoimmune disease.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 22080861.
- Also identified by DOI 10.1172/JCI60001 and PMC identifier 3226009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Genome-wide association studies (GWAS) have identified a large number of SNPs that are linked to human autoimmune diseases. However, the functional consequences of most of these genetic variations remain undefined. T cell protein tyrosine phosphatase (TCPTP, which is encoded by PTPN2) is a JAK/STAT and growth factor receptor phosphatase that has been linked to the pathogenesis of type 1 diabetes, rheumatoid arthritis, and Crohn's disease by GWAS. In this issue of the JCI, Wiede and colleagues have generated a T cell-specific deletion of TCPTP and identified a novel role for this phosphatase as a negative regulator of TCR signaling. These data provide new insight as to how noncoding PTPN2 SNPs identified in GWAS could drive human autoimmune diseases.
Medical subject headings
- Autoimmune Diseases
- Immune Tolerance
- Protein Tyrosine Phosphatase, Non-Receptor Type 2
- Receptors, Antigen, T-Cell
- T-Lymphocyte Subsets